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Langerhans Cells Facilitate UVB-Induced Epidermal
Carcinogenesis
Julia M. Lewis1, Christina D. Bürgler1, Marianna Freudzon1, Kseniya Golubets1, Juliet F. Gibson1,
Renata B. Filler1 and Michael Girardi1
UVB light is considered the major environmental inducer of human keratinocyte (KC) DNA mutations, including
within the tumor-suppressor gene p53, and chronic exposure is associated with cutaneous squamous cell
carcinoma formation. Langerhans cells (LCs) comprise a dendritic network within the suprabasilar epidermis, yet
the role of LCs in UVB-induced carcinogenesis is largely unknown. Herein we show that LC-intact epidermis
develops UVB-induced tumors more readily than LC-deﬁcient epidermis. Although levels of epidermal
cyclopyrimidine dimers following acute UVB exposure are equivalent in the presence or absence of LCs,
chronic UVB-induced p53 mutant clonal islands expand more readily in association with LCs, which remain
largely intact and are preferentially found in proximity to the expanding mutant KC populations. The observed LC
facilitation of mutant p53 clonal expansion is completely αβ and γδ T-cell independent and is associated with
increased intraepidermal expression of IL-22 and the presence of group 3 innate lymphoid cells. These data
demonstrate that LCs have a key role in UVB-induced cutaneous carcinogenesis and suggest that LCs locally
stimulate KC proliferation and innate immune cells that provoke tumor outgrowth.
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INTRODUCTION
Chronic UVB light exposure is a major risk factor for
development of premalignant actinic keratoses and malignant
squamous cell carcinoma (SCC), each harboring frequent
mutations in the master cell cycle regulator TP53 (p53) gene
(Ziegler et al., 1994). Initiating mutations largely result from
unrepaired cyclopyrimidine dimers (CPDs). Promoting
oncogenetic alterations, e.g., RAS (Daya-Grosjean et al.,
1993) and NOTCH (Durinck et al., 2011), may result from
continued UV exposure, immune inﬂuences, and other
stimuli that drive keratinocyte (KC) proliferation, dedifferen-
tiation, transformation, and ultimately tumor outgrowth
(reviewed in Epstein, 1983; Kripke, 1984). Situated adjacent
to basal and folliculo-infundibullar KCs that give rise to
actinic keratoses and SCC neoplasia is a network of dendritic
CD207+ (Langerin+) intraepidermal Langerhans cells (LCs)
that (1) survey the epidermis (Nishibu et al., 2006) for
evidence of toxin/microbial penetration (Kubo et al., 2009)
and (2) serve as antigen-presenting cells for the activation
T cells resident in the skin (Seneschal et al., 2012) or after
migration to draining lymph nodes (Kaplan et al., 2005; Bobr
et al., 2012).
We have previously suggested that LCs may function as key
players in the epithelial stress response, where they coordi-
nate with resident γδ T cells and αβ natural killer (NK) T cells
(Strid et al., 2008). γδ T cells (Girardi et al., 2001, 2003),
including resident γδ dendritic epidermal T cells (DETCs)
(Strid et al., 2008; MacLeod et al., 2014), may mediate diverse
antitumor activities, while LCs have been shown to facilitate
chemical carcinogenesis by enhancing mutagenesis (Modi
et al., 2012) and tumor promotion (Lewis et al., 2014).
Moreover, the role of LC in the well-established phenomenon
of UV-induced immune suppression is unclear, with some
evidence suggesting that LC are not necessary (Wang et al.,
2009) and other studies suggesting that LCs may have a
critical role (Fukunaga et al., 2010). Hence, we sought to
determine whether locally resident LC inﬂuence events
relevant to UV induction of cutaneous SCC, and if so,
whether such inﬂuences are dependent on adaptive and
innate immunity afforded by αβ and/or γδ T cells. We utilized
mice rendered genetically deﬁcient in LCs (Kaplan et al.,
2005), and/or αβ and γδ T cells, and studied the impact on
several fundamental steps of UVB-induced cutaneous carci-
nogenesis, including direct genotoxicity (CPD formation), p53
mutant clonal KC development and expansion, and tumor
outgrowth. Herein, we reveal that LC exert T-cell-indepen-
dent pro-tumor effects largely via the promotion of clonal
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expansion in association with enhanced epidermal expression
of IL-1β, IL-6, IL-23, and nitric oxide synthase 2, inducible
(NOS2), as well as augmented expression of the epithelial
growth factor IL-22. In addition, we observe group 3 innate
lymphoid cells (ILC3) capable of IL-22 production in
chronically UVB irradiated epidermis. Furthermore, we
identify a major T-cell-independent role for LCs in the
regulation of the epidermal stress response more generally.
RESULTS
LCs enhance chronic UVB-induced cutaneous tumor outgrowth
To assess the collective effect of chronic UVB exposure on the
emergence of cutaneous tumors, hairless (hr/hr) LC-deﬁcient
hu-Langerin-DTA transgenic (DTA) mice (Kaplan et al., 2005)
were compared with LC-intact normal littermate controls
(NLC) for tumor induction by 3× weekly UVB irradiation of
dorsal skin. LC-intact mice showed a substantially higher rate
of UVB-induced tumor development (mean 5.10± 1.18 vs.
2.44± 0.47 tumors/mouse at 18 weeks; P= 0.002) (Figure 1a),
as well as a greater accumulating tumor volume over this time
(Figure 1b). UVB exposure has been shown to compromise
intraepidermal LC numbers via induction of apoptosis and
stimulation of LC migration (Aberer et al., 1986; Nishibu et al.,
2006). Thus we considered the possibility that the observed
pro-tumor inﬂuence of LC might be due to early events, e.g.,
speciﬁcally by facilitating KC DNA damage.
LCs do not affect UVB-induced CPDs in neighboring KCs
In chemical carcinogenesis, LCs are associated with dimethyl-
benz[a]anthracine-induced genotoxicity in adjacent KCs
(Modi et al., 2012). As LCs are also associated with
accelerated UVB-induced tumor development, we consid-
ered the possibility that CPD formation might occur more
readily in the presence of LCs. Given that γδ DETCs have
shown the capacity to facilitate CPD repair (MacLeod et al.,
2014) and LC and γδ DETCs form tightly regulated cell
contacts following epidermal stress (Strid et al., 2008), we also
considered whether LCs might effect the efﬁcient repair of
CPDs within KCs. Groups of LC-intact (NLC) and LC-deﬁcient
(DTA) mice were irradiated with a single dose of 50 or 100
J m− 2 UVB, and epidermal sheets were harvested at 1 hour to
assess for acute UVB-induced CPD formation and at 24 hours
to assess CPD repair (Figure 2a and b; Supplementary Figure
S1 online). CPDs were observed diffusely within basal KCs
1 hour after UVB exposure, signiﬁcantly higher at 100 J m−2
than at 50 J m−2 but indistinguishable between similarly
exposed NLC and DTA mice. At 24 hours after UVB exposure,
CPD level decreased comparably between NLC and DTA skin
(Figure 2a and b) while LC numbers were maintained
throughout (Figure 2c). These data suggest that LCs do not
signiﬁcantly inﬂuence CPD formation following UVB exposure,
nor do they appear to affect DNA repair in the ﬁrst 24 hours
following exposure. Thus we focused further experiments on
the effects of LCs on KCs during chronic UVB exposure.
LC numbers are largely maintained in chronically UVB-
irradiated epidermis
Prior studies have demonstrated the sensitivity of LCs to acute
UVB-induced apoptosis, as well as the capacity of UVB to
trigger LC migration to draining lymph nodes (Aberer et al.,
1986; Nishibu et al., 2006). UVB can also precipitate epider-
motropism and differentiation of peripheral blood Gr1+
monocytes into CD207+ dendritic cells (DCs) (Merad et al.,
2002) followed by a second wave of steady-state precursor-
derived long-term LCs (Seré et al., 2012) to repopulate the LC
compartment. Few studies, however, have quantiﬁed the net
effects of chronic UVB exposure on the intrapepidermal LC
population. As it was unlikely that the increased tumor
susceptibility observed in LC-intact skin (Figure 1) was due to
LC enhancement of direct DNA damage in adjacent KCs
(Figure 2), we hypothesized that under chronic low-dose UVB
exposure net LC numbers would remain largely intact.
Untreated NLC and DTA mice displayed comparable γδ
DETC density (Figure 3a, b and c), consistent with prior
reports (Kaplan et al., 2005). Following 5 weeks chronic UVB
exposure, within NLC mice we found that the LC compart-
ment was largely maintained; in contrast, intraepidermal γδ
T cells were nearly eliminated in both NLC and DTA,
consistent with the exquisite sensitivity (Ho et al., 1991) of
DETCs to UVB-induced apoptosis (Figure 3a, b and c).
LCs promote p53 mutant KC clonal island expansion and are
preferentially found in association with the p53 mutant islands
To address the potential role of LCs in the enhancement of
clonal expansion, hairless (hr/hr) LC-intact (NLC) and LC-
deﬁcient (DTA) mice were exposed to UVB, and p53 mutant
KC clonal islands were quantiﬁed at 5 and 9 weeks (e.g.,
6–10 weeks prior to tumor onset). “p53 islands” can be
identiﬁed in UVB-exposed epidermis by staining with an
antibody that binds to both native and mutant p53 but at
markedly higher levels in KCs harboring mutant p53 due to
the absence of negative feedback. Direct sequencing of
p53 has shown that such p53-immunopositive islands are
mutant and clonal (Zhang et al., 2001). To conﬁrm active
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Figure 1. Langerhans cells (LCs) inﬂuence UVB-induced cutaneous tumor
development. Carcinogenesis was induced in hairless (hr/hr) LC-intact
(normal littermate controls (NLC)) and LC-deﬁcient (hu-Langerin-DTA
transgenic (DTA)) mice by exposure to 400 J m−2 UVB three times per week.
Increased (a) tumor number and (b) volume were seen in the presence of LC
(n= 10 NLC, 9 DTA, *Po0.05, **Po0.01, ***Po0.001). (c) Representative
images from a and b.
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proliferation of the p53 mutant KCs, we performed co-staining
with Ki-67 (Supplementary Figure S2 online). Although p53
island number and basal area occupied were comparable
between NLC and DTA mice at 5 weeks, NLC showed a
450% greater number of p53 islands and a4100% increase
in the basal area involved at 9 weeks (Figure 3d and e;
Supplementary Figure S3 online), with similar results seen
when hair-bearing FVB.NLC and FVB.DTA mice were
compared (Supplementary Figure S4 online).
Thus persistent and/or repopulating LCs are available in
sufﬁcient numbers under chronic UVB exposure to inﬂuence
epidermal tumor outgrowth. Moreover, LCs were preferen-
tially found within or adjacent to p53 clonal islands (Figure 3f
and i, Supplementary Figure S3 online), with a ~40%
increase in LC density in association with the mutant KCs
after 9 weeks of chronic UVB exposure (Figure 3i, 617± 35
mm− 2 island associated, 448± 44mm−2 not associated,
P=0.0065). Phenotypic analysis of LCs isolated from chronic
UVB-exposed epidermis revealed upregulation of CD207 and
major histocompatibility complex II (MHC-II), consistent with
LC activation, but without changes in C-C chemokine
receptor 7 or C-X-C chemokine receptor 4 expression, which
might have otherwise indicated an increased capacity for
migration to draining lymph nodes (Supplementary Figure S5
online).
LC enhancement of p53 mutant KC clonal expansion is T-cell
independent
As LCs may function as antigen-presenting cells, we
next assessed the contribution of αβ and γδ T cells to the
mechanism of LC enhancement of p53 mutant KC clonal
expansion. DTA mice were intercrossed to TCRβ− /−
(deﬁcient in all αβ T-cell populations) and TCRδ− /−
(deﬁcient in all γδ T-cell populations). LC-intact but T cell-
deﬁcient (TCRβ− /− δ− /− .NLC) mice were compared with
LC-deﬁcient and T-cell-deﬁcient (TCRβ− /− δ− /− .DTA)
mice for the development and expansion of p53 mutant KC
islands under chronic UVB exposure (Figure 4). In the
complete absence αβ or γδ T cells, p53 island development
and growth was again substantially enhanced in the presence
of LCs. Following 9 weeks of UVB exposure, p53 island
density was 86% increased in TCRβ− /− δ− /− .NLC versus
TCRβ− /− δ− /− .DTA (Figure 4a, 79.9± 4.5 vs. 42.9± 4.3
cm− 2, Po0.0001) and p53 island area was increased by
135% (Figure 4b, 10661± 1188 vs. 4520±711 μm2 p53
islandmm− 2, P= 0.0004). The lack of requirement for αβ
T cells suggests that the mechanism does not involve LC
stimulation of immunosuppressive αβ regulatory T cells
(Shreedhar et al., 1998) or NK T cells (Fukunaga et al.,
2010) previously implicated in UV-induced immune suppres-
sion, γδ T cells with the capacity for cytotoxicity of
transformed KCs (Girardi et al., 2001), or pro-inﬂammatory
αβ (Kwong et al., 2010) and γδ (Wakita et al., 2010) T-cell
subsets that might drive mutant KC proliferation. The striking
parallel of the dependence on LCs for increased p53 island
number and size, as well as the LC association with the
expanding p53 islands, observed in both T-cell-intact (Figure
3d, e and i) and T cell-deﬁcient (Figure 4a, b and c) mice,
underscores the fundamental pro-tumor contribution of LCs
and suggested an underlying paracrine effect.
We thus sought to quantify within naive and chronically
UVB-irradiated TCRβ− /− δ− /− .NLC and TCRβ− /− δ− /− .
DTA epidermis the expression levels of several epithelial
growth factors previously implicated in paracrine stimulation
of epithelial proliferation and neoplasia (Figure 4d): epidermal
growth factor (Chan et al., 2004), amphiregulin (Rittié et al.,
2006), insulin-like growth factor-1 (DiGiovanni et al., 2000),
keratinocyte growth factor-1/ﬁbroblast growth factor-7
(Jameson et al., 2002; Chikama et al., 2008), and IL-22
(Briso et al., 2013; Rabeony et al., 2014). Epidermal cells from
the non-irradiated skin of TCRβ− /− δ− /− .NLC and TCRβ−
/− δ− /− .DTA revealed expression proﬁles consistent with
constitutive expression of IL-22 within LC-intact epidermis
(mean fold change untreated DTA= 1.0± 0.1 vs. untreated
NLC=8.4±2.1, P= 0.0023), with levels of such substantially
elevated following chronic UVB exposure (DTA+UVB= 1.6
± 0.1 vs. untreated DTA, P= 0.0029; NLC+UVB= 52.5± 7.1
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Figure 2. Langerhans cells (LCs) do not affect UVB-induced cyclopyrimidine
dimer (CPD) formation. (a) Hairless (hr/hr) LC-intact (normal littermate
controls (NLC)) and LC-deﬁcient (LC-deﬁcient hu-Langerin-DTA transgenic
(DTA)) mice were treated with a single dose of UVB and epidermal sheets
prepared 1 or 24 hours later and stained with antibodies directed against
thymine dimers (CPD) and CD207 plus the nuclear dye To-Pro-3 (shown in
Supplementary Figure S1 online). CPD ﬂuorescence intensity was similar in
LC-intact and LC-deﬁcient mice. (b) Representative images from a show CPD
(red) and LC (CD207, green). Scale bar=20 μm. (c) LC density does not
change during the 24 hours following a single dose of UVB. n=3–8 mice/
group; in c, each symbol represents one mouse. NS, not signiﬁcant.
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Figure 3. Langerhans cells (LCs) persist during chronic UVB exposure and facilitate p53 island formation. CD207+ LC and TCRγδ+ dendritic epidermal T cells
(DETCs) were quantiﬁed in epidermal sheets prepared from untreated versus chronic UVB-treated (400 J m− 2, 3× /week, 5 weeks) (a) LC-intact normal littermate
controls (NLC) and (b) LC-deﬁcient hu-Langerin-DTA transgenic (DTA) hr/hr mice. (c) Representative images show CD207 (green) and TCRγδ (red) staining. In
both NLC and DTA mice, DETCs are nearly eliminated by chronic UVB treatment; however, LC in NLC mice are present at 66% of control levels following
5 weeks UVB exposure; *Po0.5, ***Po0.001, n=6 mice/group. Mutant keratinocyte p53 (d) island density and (e) area were quantiﬁed in epidermal sheets
prepared from n=6 NLC and DTA hr/hr mice following 5 or 9 weeks of UVB exposure. Inset graphs show distribution at 9 weeks; each symbol represents one
mouse, **Po0.01, ***Po0.001. (f and h) Representative images of p53 islands (red) and CD207+ LC (green), scale bar=20 μm, and (g) a 3D rendering
of p53 (green) and LC (blue). (i) CD207+ LC density is increased in association with p53 islands; **Po0.01. Quantitation is described in Supplementary
Figure S3 online.
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vs. untreated NLC, P=0.0013) and signiﬁcantly higher in the
presence of LCs (DTA+UVB vs. NLC+UVB, Po0.0001). In
contrast, there were modest relative decreases or no
discernible changes in the other assessed epithelial growth
factors (Figure 4d). UVB-exposed LC-intact epidermis also
displayed the highest levels of expression of IL-1β and IL-6,
and to a lesser extent IL-23a (Figure 4e), cytokines known to
stimulate production of IL-22 by adaptive αβ+ and γδ+ Th22
cells as well as innate immune cells, e.g., NK and innate
lymphoid cells (ILC) (Ahlfors et al., 2014). NOS2, known to
foster reactive oxygen species within the epidermis after UVB
exposure (Chang et al., 2003), was also the highest in UVB-
exposed LC-intact epidermis. Furthermore, exposure of
puriﬁed LCs to UVB in vitro resulted in increased expression
of IL-1β, IL-6, and IL-23a (Supplementary Figure S6 online),
suggesting that at least a portion of the observed epidermal
expression of these cytokines was attributable directly to LCs,
as opposed to augmented production by KCs in the presence
of LCs. Taken together, these data suggest that LC-intact
epidermis demonstrates enhanced KC and/or LC production
of IL-1β, IL-6, and (to a lesser extent) IL-23, which in turn
supports local production of IL-22 by non-T (e.g., NK and/or
ILC) cells.
IL-22-producing ILC3 populate chronically UVB-exposed skin
To determine the spectrum of immune cell populations
present in T-cell-deﬁcient LC-intact versus LC-deﬁcient skin,
suspensions prepared from TCRβ− /− δ− /− .NLC and
TCRβ− /− δ− /− .DTA mice were analyzed by ﬂow cytome-
try (Supplementary Figure S7 online). The only discernible
difference in CD45+ MHC-II+ cells from TCRβ− /− δ− /− .
NLC relative to TCRβ− /− δ− /− .DTA skin was, as expected,
the presence of LC populations (CD45+ MHC-II+ CD11b+
CD207+ CD103− ) that included epidermal LC as well as
apparent dermal “in transit”migratory LCs (Henri et al., 2010).
Although reduced in number following chronic UVB
exposure, we found comparable levels between LC-intact
and LC-deﬁcient skin of the major dermal DC population
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Figure 4. Langerhans cell (LC) facilitation of p53 island growth is T-cell independent. Mutant keratinocyte p53 (a) island density and (b) area were quantiﬁed in
epidermal sheets prepared from TCRβ− /− δ− /− .NLC (normal littermate controls) and TCRβ− /− δ− /− .DTA (LC-deﬁcient hu-Langerin-DTA transgenic) mice
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(CD45+ MHC-II+ CD11b+ CD207− CD103− ), the minor
Langerin+ dermal DC population (CD45+MHC-II+ CD11b−
CD207+ CD103+), and other dermal (CD45+ MHC-II+
CD11b− CD103− ) DCs. The epidermis of both TCRβ− /
− δ− /− .NLC and TCRβ− /− δ− /− .DTA also harbors a
population of CD45+ MHC-II− CD11b− IL-7R+ CD103+
cells that would be expected to contain ILC, and cells of
this phenotype seemingly persist in UVB-treated skin
(Supplementary Figure S8 online). Isolation and further
analysis of both protein (ﬂow cytometry) and mRNA
(quantitative real time–PCR) expression (Figure 5) revealed
the predominant differentiation phenotype to be consistent
with IL-22-producing RORγt+ (Tbet− GATA3− ) ILC3
(reviewed in Artis and Spits, 2015). The proportion
of CD45+ MHC-II− epidermal ILC observed in TCRβ− /
− δ− /− mice may be increased relative to that found in
T-cell-intact mice as a compensatory mechanism similar to
that previously reported for various immune cell populations
in genetically modiﬁed mouse models, including cutaneous
ILC (Roediger et al., 2013). Nonetheless, these ILC persist in
chronically UVB-exposed epidermis, unlike DETCs, and the
expression of IL-22 by these cells was substantially higher in
LC-intact epidermis after chronic UVB exposure (Figure 5),
consistent with their activation and differentiation being
positively inﬂuenced by both the presence of LCs and
epidermal exposure to UVB.
The implication of LCs herein as a major contributor to
UVB-induced p53 mutant KC clonal expansion via the
enhancement of local production of IL-22 by ILC3, indepen-
dently of resident or inﬁltrating T cells, suggests that LC may
also have a more general role in epidermal homeostasis,
including supporting KC proliferation as part of the epidermal
stress response. Consistent with this hypothesis, at 5 weeks of
UVB-exposure (a time with minimal difference in p53 island
number and size between TCRβ− /− δ− /− .NLC and TCRβ−
/− δ− /− .DTA; Figure 3d and e), we were able to detect
greater epidermal thickness in association with the presence
of LCs (Figure 6a and b). Removal of the stratum corneum and
superﬁcial KCs by repetitive tapestripping (Kuo et al., 2013)
resulted in a greater transepidermal waterloss in TCRβ− /
− δ− /− .NLC versus TCRβ− /− δ− /− .DTA epidermis
(Figure 6c). More aggressive disruption of the epidermis by
repetitive razor abrasion resulted in an even greater transe-
pidermal waterloss in LC-intact epidermis that showed
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multiple comparisons. (b) Epidermal cells from individual untreated and 9-week chronic UVB-treated TCRβ− /− δ− /− .NLC and TCRβ− /− δ− /− .DTA mice
were stimulated with phorbol 12-myristate 13-acetate+Ionomycin and IL-22 production was assessed by ﬂow cytometry. Top panels show CD45+
MHC-II− gating, lower panels are gated on CD45+ MHC-II− cells. Plots are representative of n=3 mice/group. (c) Percentage of IL-22-producing CD45+
MHC-II− epidermal cells; each symbol represents one mouse, **Po0.01. MHC, major histocompatibility complex.
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histological evidence of epidermal hyperplasia and hyperker-
atosis (Figure 6d and e) and augmented expression of IL-22,
IL-1β, and IL-23 (Supplementary Figure S9 online). Further-
more, a single application of 12-O-tetradecanoylphorbol-13-
acetate (TPA) provoked a greater ear swelling response in
LC-intact skin (Figure 6f), while chronic TPA application
ultimately showed enhanced epidermal thickening in asso-
ciation with the presence of LC (Figure 6g). These data are all
consistent with LC serving as fundamental contributors to the
epidermal stress response via stimulation of KC proliferation
and dedifferentiation, independently of the presence of αβ
and γδ T cells and regardless of the mode of epidermal
damage (e.g., UV radiation, physical disruption, chemical
irritant).
DISCUSSION
Immune cells resident within epithelial tissue have key roles
in microbial defense and barrier homeostasis, and the
activities of such cells may arrest or enhance carcinogenesis
(Strid et al., 2008; Yu et al., 2014). The demonstration herein
of a major role for LCs in UVB-induced skin carcinogenesis,
as well as in the response to epidermal perturbation, further
elucidates LCs as fundamental regulators of epidermal
homeostasis. The pro-carcinogenic effect of LCs during UVB
exposure is counter to the notion of LCs as key players in
tumor immunosurveillance. Moreover, the demonstration that
the association of LCs with p53 mutant KC clonal expansion is
completely independent of the presence of αβ and γδ T cells
favors a mechanism in which LCs are directly affecting mutant
KCs and/or stimulating non-T (NK and/or ILC) immune cells to
induce an intraepidermal environment conducive to mutant
KC survival and growth.
During chronic UVB exposure, the LC network remained
largely intact (Figure 3). Whether the observed LC numbers
were reﬂective more of a relative resistance to apoptosis of the
initial resident population of LCs derived from fetal pre-
cursors, or from repopulating sources such as peripheral
blood monocytes, is unclear. Nonetheless, Ki-67 staining
reveals little evidence of active proliferation of LCs, in contrast
to the clonally expanding mutant KCs (Supplementary Figure
S2 online). The intimate association of LCs with the clonally
expanding KC islands suggests the possibility that LCs detect
and respond to dysregulated KCs or that the mutated KCs
produce chemoattractant and/or survival factors for the LCs.
Further investigation will be necessary to determine the
relative contribution of LC enhancement of p53 mutant KC
clonal expansion by direct (e.g., by local production of
growth and/survival factors) versus indirect (e.g., by stimula-
tion of other cells that produce growth and/or survival factors)
inﬂuences and whether the LCs within expanding islands are
functionally distinct from LCs not found in association with
mutant KCs.
Our expression analysis of LC-intact and LC-deﬁcient
epidermal preparations, prior to and after chronic UVB
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Figure 6. Langerhans cells (LCs) contribute to the epidermal stress response in a T-cell-independent manner. (a) Epidermal hypertrophy is greater in LC-intact
TCRβ− /− δ− /− .NLC (normal littermate controls) than in LC-deﬁcient TCRβ− /− δ− /− .DTA (LC-deﬁcient hu-Langerin-DTA transgenic) mice following chronic
UVB exposure (400 J m−2, 3× /week, 5weeks) as evaluated by measuring the minimal epidermal thickness. (b) Representative images of a. Transepidermal
waterloss (TEWL) is equivalent at baseline but increased in LC-intact mice 48 hours after (c) tapestripping as well as 4 days after epidermal abrasion by (d)
repetitive razor shaving. (e) Representative images of d. (f) Ear thickness following a single 12-O-tetradecanoylphorbol-13-acetate (TPA) application and (g)
minimal epidermal thickness following twice weekly TPA for 4 weeks are greater in the presence of LCs. Each symbol represents one mouse in a, c, d, and g; n= 7
NLC and 7 DTA in f. NS, not signiﬁcant.
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exposure, has provided insight into the nature of LC
promotion of clonal expansion. Epidermal relative expression
of IL-1β, IL-6, and IL-23 were each observed to increase with
UVB exposure in LC-deﬁcient (TCRβ− /− δ− /− .DTA) skin,
consistent with known production of these cytokines by
stressed KCs. In the presence of LCs (in TCRβ− /− δ− /− .
NLC), UVB-induced expression was signiﬁcantly enhanced
for IL-1β and IL-6. Moreover, the substantial increase in the
expression of IL-1β in naive LC-intact versus LC-deﬁcient
epidermis (i,e., prior to UVB exposure) suggest that LCs may
also have a role in homeostatic regulation of the epidermis.
The augmented IL-22 expression observed in LC-intact skin
chronically exposed to UVB is entirely consistent with
increases in IL-1β, IL-6, and IL-23—all known stimulators of
IL-22 production.
Phenotypic analysis revealed that the augmented IL-22
production observed in association with the presence of LC
and chronic UVB exposure may be attributable to RORγt+
ILC3 (reviewed in Artis and Spits, 2015). Thus UVB-exposed
LC-intact epidermis supports an environment for the aug-
mented expression by ILC3 of IL-22, a cytokine noteworthy
for its stimulation of KC proliferation and de-differentiation,
skin wound healing, and well-established association with
epithelial carcinogenesis (reviewed in Lim and Savan, 2014).
The receptor for IL-22 is primarily expressed by epithelial
cells, including KCs, as a heterodimer (IL-22R1 and IL-10R2)
that stimulates Stat3 activation, and a pro-carcinogenic role
for IL-22 has been shown in models of colonic, lung, and
hepatocellular carcinoma. Moreover, IL-22-producing ILCs
were shown to be the principal drivers of dysplasia in a model
of inﬂammatory bowel disease–associated colorectal cancer
(Kirchberger et al., 2013).
The augmented local expression of IL-1β, IL-23, and IL-22
following razor abrasion in the presence of LCs
(Supplementary Figure S9 online) is also consistent with our
observed responses to epidermal perturbation in (T-cell-
deﬁcient) LC-intact skin: increased epidermal hypertrophy,
compromised epidermal barrier function, and augmented
irritant response (Figure 6). Recombinant IL-22 can promote
the in vitro survival and proliferation of KCs after mechanical
disruption (Eyerich et al., 2009) and epidermal hypertrophy
and dedifferentiation in reconstituted human epidermis
(Rabeony et al., 2014). As LC numbers are largely main-
tained in human actinic keratoses (Shevchuk et al., 2014) and
epidermal LC levels in organ transplant recipients are
equivalent to controls (Sandvik et al., 2014), it is logical to
investigate whether LCs are contributing to human SCC
development. Clearly, further studies are necessary to more
fully elucidate the relationship of LCs, ILC3, and IL-22 to
epidermal homeostasis and UVB-induced cutaneous
carcinogenesis.
MATERIALS AND METHODS
Animals and housing
FVB/N, DTA, NLC, TCRβ− /− TCRδ− /− (TCRβ− /− δ− /− .NLC)
and TCRβ− /− TCRδ− /− LC-deﬁcient (TCRβ− /− δ− /− .DTA) mice
were previously described (Modi et al., 2012). Hairless mice (hr/hr,
FVB/N background) were generously provided by Dr Donna Kusewitt
(The University of Texas MD Anderson Cancer Center, Houston, TX).
All in vivo studies were approved by the Yale Animal Care and Use
Committee.
UVB exposure
At age 7 weeks, hair was removed from the dorsal skin of female
TCRβ− /− δ− /− .NLC and TCRβ− /− δ− /− .DTA mice by clipping
plus depilatory cream; hr/hr mice were untreated. UVB exposures
began at age 8 weeks using a bank of four FS20T12 broadband-UVB
bulbs (National Biological, Corp., Twinsburg, OH) with emitted light
ﬁltered (Kodacel TA422, Eastman Kodak, Rochester, NY) to remove
wavelengths o290 nm. Exposure was monitored using a calibrated
meter and probe (Intensity Meter 200, G&R Labs, Santa Clara, CA).
Chronic exposure consisted of 400 J m−2 3× /weekly.
Tumor assessment
Tumors were measured, counted (when ⩾ 1mm2), and scored
weekly as clinically apparent papillomas or carcinomas by a blinded
observer as previously described (Girardi et al., 2003). Tumor volume
was calculated as: 4/3πr3 where r= (L×W)/2.
Immunoﬂuorescence and confocal microscopy
Epidermal sheets were prepared and stained as previously described
(Lewis et al., 2014) with anti-CD207 (RMUL.2, eBioscience, San
Diego, CA), anti-TCRγδ (GL3, Becton Dickinson, Franklin Lakes, NJ),
and anti-p53 (NCL-p53-CM5p, Leica Biosystems, Buffalo Grove, IL)
followed by ﬂuorescent species-speciﬁc secondaries (Jackson
Immunoresearch, West Grove, PA). Z-stacked images (20/mouse)
were collected (Zeiss 510Meta confocal, Carl Zeiss Microscopy,
Thornwood, NY) in a set pattern and Volocity 6.2 (Perkin Elmer,
Waltham, MA) used to quantitate LCs and DETCs. CPD staining and
quantiﬁcation is described in Supplementary Figure S1 online and
p53 island quantiﬁcation in Supplementary Figure S3 online.
Epidermal cell suspensions and ﬂow cytometry
Epidermal cell suspensions were prepared as described (Strid et al.,
2008). For intracellular cytokine detection, cells were stimulated for
18 hours with 50 ngml− 1 phorbol 12-myristate 13-acetate plus 1
μg ml−1 ionomycin. Monensin (2 μM) was added for the ﬁnal 6 hours
plus Brefeldin A (10 μgml−1) for the ﬁnal 2 hours. Samples were
blocked (2.4G2, BD Biosciences, San Jose, CA) and stained with
antibodies to CD45 (30-F11, Biolegend, San Diego, CA), MHC-II
(M5/114.15.2, eBioscience), IL-22 (Poly5164, Biolegend), or isotype
controls, plus viability dye EMA. BD Biosciences CytoFix/CytoPerm
Kit was used for ﬁxation and permeabilization. Data were collected
on Stratedigm S1000EX (Stratedigm, San Jose, CA) and analyzed
with FlowJo (LLC, Ashland, OR). Cell sorting, to obtain CD45+
MHC-II− epidermal ILC, was performed on MoFlo (Beckman
Coulter, Brea, CA).
Gene expression analysis
RNA was isolated (RNeasy, Qiagen, Valencia, CA) and transcribed
(High-Capacity cDNA Reverse Transcription Kit, ABI, Carlsbad, CA).
Quantitative real time–PCR (ABI 7500, SDS 2.0 software) was
performed using Taqman assays and Taqman Gene Expression
Mastermix (ABI). Ct values were normalized to β-actin, and
expression differences relative to untreated DTA were calculated
using RQ= 2−ΔΔCt.
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Epidermal stress response assays
Transepidermal waterloss was measured using the Tewameter
TM300 (probe 06030433, Courage & Khazaka, Cologne, Germany).
Tape-stripping consisted of three repetitions of adhesive tape application
(Scotch Magic tape, 3M, St Paul, MN) performed 1 week following
hair removal. Epidermal abrasion was induced by twice repeated
shaving of ventral skin (Personna American Safety Razor, Verona, VA).
Ear thickness following a single application of TPA (Sigma, St. Louis,
MO, 0.5 nmoles) was measured using an engineer’s micrometer
(Mitutoyo 7301, Aurora, IL). Epidermal hypertrophy was induced
by TPA (20 nmoles) application 2× /week for 4 weeks. Histological
examination and measurement of minimal epidermal thickness was
performed as previously described (Lewis et al., 2014).
Statistical analysis
Statistical signiﬁcance of differences in tumor number and volume
(Figure 1) and ear thickness (Figure 6f) over time were assessed using
repeated-measures analysis of variance with Sidak’s correction for
multiple comparisons. Differences in relative gene expression were
assessed using Student’s t-test for unpaired data with Holm–Sidak
correction for multiple comparisons and establishment of signiﬁ-
cance. Other experimental groups were compared using one-tailed
Student’s t-test for unpaired data with signiﬁcance established at
Po0.05. All statistical analyses were performed with the GraphPad
Prism 6.0 software (GraphPad Software, Inc., La Jolla, CA).
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